The ABCC4-PDZ peptide also specifically sensitized MO7e cells to cytarabine (aka Ara-C), another chemotherapeutic drug used in AML therapy that forms nucleotide substrates that are ABCC4 substrates (Fig. 4d). The gene discussed is ABCC4; the disease is acute myeloid leukemia.